tetano
Editor, Senior Moderator
Ultrasound Obstet Gynecol. 2020 Apr 18. doi: 10.1002/uog.22049. [Epub ahead of print]
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.
Kwiatkowski S[SUP]1[/SUP], Borowski D[SUP]2[/SUP], Kajdy A[SUP]3[/SUP], Poon LC[SUP]4[/SUP], Rokita W[SUP]5[/SUP], WielgoŚ M[SUP]6[/SUP].
Author information
Abstract
With the current outbreak and spread of the coronavirus disease 2019 (COVID-19) worldwide many questions arise. There have been issued precautions regarding the use of anti-inflammatory medications, including aspirin. To our knowledge, there is insufficient data to suggest an increased risk between prophylactic use of low-dose aspirin and progression of COVID-19 infection in pregnant women at risk of placental complications. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
PMID:32304612DOI:10.1002/uog.22049
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.
Kwiatkowski S[SUP]1[/SUP], Borowski D[SUP]2[/SUP], Kajdy A[SUP]3[/SUP], Poon LC[SUP]4[/SUP], Rokita W[SUP]5[/SUP], WielgoŚ M[SUP]6[/SUP].
Author information
Abstract
With the current outbreak and spread of the coronavirus disease 2019 (COVID-19) worldwide many questions arise. There have been issued precautions regarding the use of anti-inflammatory medications, including aspirin. To our knowledge, there is insufficient data to suggest an increased risk between prophylactic use of low-dose aspirin and progression of COVID-19 infection in pregnant women at risk of placental complications. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
PMID:32304612DOI:10.1002/uog.22049